Federica Sella

8PUBLICATIONS
87CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 23, 2024
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma.

Sapir Cohen Shvefel, Joy A Pai, Yingying Cao

|Aug 29, 2024
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma.

Florentia Dimitriou, Phil F Cheng, Annalisa Saltari

|Jun 25, 2024
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.

Mauro Esposito, Laura Yerly, Prachi Shukla

|Nov 15, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Sarah Proteau, Imène Krossa, Chrystel Husser

|Sep 20, 2023
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma.

Lorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli

|Aug 10, 2023
Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma.

Ulrike Lischetti, Aizhan Tastanova, Franziska Singer

Pageof 2

Frequent Collaborators

6 joint publications

Mitchell P Levesque

3 joint publications

Aizhan Tastanova

2 joint publications

Yardena Samuels

2 joint publications

Sacha Nahon-Estève